Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 22494844)

1.

Design and synthesis of 4-O-methylhonokiol analogs as inhibitors of cyclooxygenase-2 (COX-2) and PGF₁ production.

Lee B, Kwak JH, Huang SW, Jang JY, Lim S, Kwak YS, Lee K, Kim HS, Han SB, Hong JT, Lee H, Song S, Seo SY, Jung JK.

Bioorg Med Chem. 2012 May 1;20(9):2860-8. doi: 10.1016/j.bmc.2012.03.028. Epub 2012 Mar 24.

PMID:
22494844
2.

Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.

Zarghi A, Ghodsi R.

Bioorg Med Chem. 2010 Aug 15;18(16):5855-60. doi: 10.1016/j.bmc.2010.06.094. Epub 2010 Jul 3.

PMID:
20650641
3.

Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.

Schühly W, Hüfner A, Pferschy-Wenzig EM, Prettner E, Adams M, Bodensieck A, Kunert O, Oluwemimo A, Haslinger E, Bauer R.

Bioorg Med Chem. 2009 Jul 1;17(13):4459-65. doi: 10.1016/j.bmc.2009.05.018. Epub 2009 May 18.

PMID:
19481465
4.

Anti-inflammatory effect of 4-O-methylhonokiol, compound isolated from Magnolia officinalis through inhibition of NF-kappaB [corrected].

Oh JH, Kang LL, Ban JO, Kim YH, Kim KH, Han SB, Hong JT.

Chem Biol Interact. 2009 Aug 14;180(3):506-14. doi: 10.1016/j.cbi.2009.03.014. Epub 2009 Mar 27. Erratum in: Chem Biol Interact. 2010 Dec 5;188(3):677.

PMID:
19539808
5.

Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.

Lu X, Zhang H, Li X, Chen G, Li QS, Luo Y, Ruan BF, Chen XW, Zhu HL.

Bioorg Med Chem. 2011 Nov 15;19(22):6827-32. doi: 10.1016/j.bmc.2011.09.034. Epub 2011 Sep 25.

PMID:
22000948
6.

Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.

Hayashi S, Ueno N, Murase A, Nakagawa Y, Takada J.

Eur J Med Chem. 2012 Apr;50:179-95. doi: 10.1016/j.ejmech.2012.01.053. Epub 2012 Feb 6.

PMID:
22373734
7.

Inhibition of prostaglandin E2 production by synthetic wogonin analogs.

Gurung SK, Kim HP, Park H.

Arch Pharm Res. 2009 Nov;32(11):1503-8. doi: 10.1007/s12272-009-2101-5.

PMID:
20091262
8.

Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors.

Zarghi A, Kakhgi S, Hadipoor A, Daraee B, Dadrass OG, Hedayati M.

Bioorg Med Chem Lett. 2008 Feb 15;18(4):1336-9. doi: 10.1016/j.bmcl.2008.01.021. Epub 2008 Jan 11.

PMID:
18226898
9.

Design, synthesis and activity of benzothiazole-based inhibitors of NO production in LPS-activated macrophages.

Jin GH, Li H, An S, Ryu JH, Jeon R.

Bioorg Med Chem Lett. 2010 Nov 1;20(21):6199-202. doi: 10.1016/j.bmcl.2010.08.112. Epub 2010 Sep 16.

PMID:
20850309
10.

Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.

Ghodsi R, Zarghi A, Daraei B, Hedayati M.

Bioorg Med Chem. 2010 Feb;18(3):1029-33. doi: 10.1016/j.bmc.2009.12.060. Epub 2010 Jan 4.

PMID:
20061161
11.

Synthesis of biflavones having a 6-O-7'' linkage and effects on cyclooxygenase-2 and inducible nitric oxide synthase.

Che H, Park BK, Lim H, Kim HP, Chang HW, Jeong JH, Park H.

Bioorg Med Chem Lett. 2009 Jan 1;19(1):74-6. doi: 10.1016/j.bmcl.2008.11.017. Epub 2008 Nov 12.

PMID:
19041241
12.

Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors.

Reddy MV, Billa VK, Pallela VR, Mallireddigari MR, Boominathan R, Gabriel JL, Reddy EP.

Bioorg Med Chem. 2008 Apr 1;16(7):3907-16. doi: 10.1016/j.bmc.2008.01.047. Epub 2008 Jan 30.

PMID:
18272371
13.

Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors.

Qiu KM, Yan R, Xing M, Wang HH, Cui HE, Gong HB, Zhu HL.

Bioorg Med Chem. 2012 Nov 15;20(22):6648-54. doi: 10.1016/j.bmc.2012.09.021. Epub 2012 Sep 21.

PMID:
23062711
14.

Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors.

Al-Hourani BJ, Sharma SK, Suresh M, Wuest F.

Bioorg Med Chem Lett. 2012 Mar 15;22(6):2235-8. doi: 10.1016/j.bmcl.2012.01.093. Epub 2012 Feb 2.

PMID:
22341941
15.
16.

Anti-oxidative and inhibitory activities on nitric oxide (NO) and prostaglandin E2 (COX-2) production of flavonoids from seeds of Prunus tomentosa Thunberg.

Kim SK, Kim HJ, Choi SE, Park KH, Choi HK, Lee MW.

Arch Pharm Res. 2008 Apr;31(4):424-8. doi: 10.1007/s12272-001-1174-9. Epub 2008 May 1.

PMID:
18449498
17.
18.

Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.

Hayashi S, Sumi Y, Ueno N, Murase A, Takada J.

Biochem Pharmacol. 2011 Oct 1;82(7):755-68. doi: 10.1016/j.bcp.2011.06.036. Epub 2011 Jul 2.

PMID:
21741371
19.

Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.

Zhou HY, Shin EM, Guo LY, Youn UJ, Bae K, Kang SS, Zou LB, Kim YS.

Eur J Pharmacol. 2008 May 31;586(1-3):340-9. doi: 10.1016/j.ejphar.2008.02.044. Epub 2008 Feb 26.

PMID:
18378223
20.

Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.

Zebardast T, Zarghi A, Daraie B, Hedayati M, Dadrass OG.

Bioorg Med Chem Lett. 2009 Jun 15;19(12):3162-5. doi: 10.1016/j.bmcl.2009.04.125. Epub 2009 May 3.

PMID:
19447036
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk